ARCHIVES

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

This article is from The Cancer Letter archive.

Vol. 29 No. 15 | April 11, 2003

Download PDF Visit The Full Archive

Related Articles

House Medicare Reform Bill Takes A smaller Bite In Drug Reimbursement

June 20, 1997

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

July 12, 2013

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009

In Brief: Treatment Reorganization Plan Due In November, Rauscher Says; Panel To Review Clinical Activities

June 27, 1975

Poverty Play Key Role In Excess Cancer Deaths Among Minorities, President’s Cancer Panel Hears

July 26, 1991

Simmons Cancer Center at UT Southwestern Wins NCI Comprehensive Designation and $7.5 Million.

September 10, 2010